Enzo Biochem (ENZ)
(Delayed Data from NYSE)
$1.16 USD
+0.05 (4.50%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $1.16 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ENZ 1.16 +0.05(4.50%)
Will ENZ be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ENZ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENZ
Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up
ENZ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ENZ
What You Missed On Wall Street This Morning
What You Missed On Wall Street On Friday
Enzo Biochem: Fiscal Q3 Earnings Snapshot
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024